We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$310M
AUM Growth
+$60.3M
Cap. Flow
+$49M
Cap. Flow %
15.81%
Top 10 Hldgs %
7.4%
Holding
817
New
340
Increased
127
Reduced
80
Closed
270

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$2.34M
2
PCG icon
PG&E
PCG
+$2.05M
3
GDDY icon
GoDaddy
GDDY
+$2.02M
4
STZ icon
Constellation Brands
STZ
+$1.93M
5
RHI icon
Robert Half
RHI
+$1.84M

Top Sells

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$2.51M
2
CRM icon
Salesforce
CRM
+$2.17M
3
CSX icon
CSX Corp
CSX
+$1.98M
4
DLTR icon
Dollar Tree
DLTR
+$1.79M
5
MLM icon
Martin Marietta Materials
MLM
+$1.74M

Sector Composition

Rank Sector Weight
1 Technology 19.82%
2 Industrials 15.73%
3 Financials 15.52%
4 Consumer Discretionary 13.8%
5 Healthcare 11.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OEC icon
501
Orion
OEC
$381M
$124K 0.04%
+11,863
New +$134K
BLMN icon
502
Bloomin' Brands
BLMN
$759M
$123K 0.04%
14,233
-51,282
-78% -$412K
VIAV icon
503
Viavi Solutions
VIAV
$8.65B
$121K 0.04%
+12,063
New +$117K
VIR icon
504
Vir Biotechnology
VIR
$1.5B
$120K 0.04%
23,820
+10,521
+79% +$56.4K
BCRX icon
505
BioCryst Pharmaceuticals
BCRX
$2.35B
$119K 0.04%
+13,317
New +$124K
HUMA icon
506
Humacyte
HUMA
$181M
$119K 0.04%
+57,000
New +$110K
EGY icon
507
Vaalco Energy
EGY
$567M
$119K 0.04%
32,868
+20,067
+157% +$69.7K
TYRA icon
508
Tyra Biosciences
TYRA
$1.97B
$118K 0.04%
12,350
+2,048
+20% +$19.5K
IRBT
509
DELISTED
iRobot
IRBT
$118K 0.04%
+37,731
New +$104K
AMPY icon
510
Amplify Energy
AMPY
$155M
$116K 0.04%
36,253
+25,456
+236% +$75.7K
VMEO
511
DELISTED
Vimeo
VMEO
$114K 0.04%
28,135
+12,189
+76% +$56.4K
UIS icon
512
Unisys
UIS
$230M
$112K 0.04%
+24,827
New +$112K
FCEL icon
513
FuelCell Energy
FCEL
$1.89B
$112K 0.04%
+19,978
New +$97K
QSI icon
514
Quantum-Si Incorporated
QSI
$157M
$112K 0.04%
+57,000
New +$84.3K
FSLY icon
515
Fastly Inc
FSLY
$3.37B
$108K 0.03%
+15,288
New +$103K
EDIT icon
516
Editas Medicine
EDIT
$413M
$104K 0.03%
+47,083
New +$77K
TROX icon
517
Tronox
TROX
$999M
$103K 0.03%
+20,397
New +$111K
OCUL icon
518
Ocular Therapeutix
OCUL
$1.85B
$99.5K 0.03%
+10,720
New +$83.9K
XNCR icon
519
Xencor
XNCR
$1.59B
$97.1K 0.03%
+12,358
New +$111K
IOVA icon
520
Iovance Biotherapeutics
IOVA
$2.09B
$97K 0.03%
56,404
+110
+0.2% +$274
BRY
521
DELISTED
Berry Corp
BRY
$95.3K 0.03%
+34,392
New +$91.9K
NPWR icon
522
NET Power
NPWR
$130M
$94.8K 0.03%
+38,401
New +$80.6K
PRME icon
523
Prime Medicine
PRME
$545M
$92.8K 0.03%
+37,587
New +$57.9K
FTRE icon
524
Fortrea Holdings
FTRE
$1.8B
$92.3K 0.03%
+18,676
New +$100K
COTY icon
525
Coty
COTY
$2.37B
$81.3K 0.03%
17,478
+5,985
+52% +$29.6K

Similar funds

AXQ Capital's Q2 2025 Portfolio in Review

As of Q2 2025, AXQ Capital held 817 positions worth $310M, up 24% from $249M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

AXQ Capital deployed $49M of net new capital in Q2 2025, opening 340 new positions and adding to 127 existing holdings. Its largest new stake was Thermo Fisher Scientific: 5,591 shares worth $2.27M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was MGIC Investment, an estimated $1.65M trimmed.

  • AXQ Capital's largest Q2 2025 buy was Thermo Fisher Scientific: 5,591 shares worth $2.27M.
  • AXQ Capital added most to PG&E in Q2 2025, an estimated $2.05M increase.
  • AXQ Capital's biggest Q2 2025 reduction was MGIC Investment, cutting an estimated $1.65M.
  • AXQ Capital fully exited NextEra Energy in Q2 2025, selling an estimated $2.51M.
  • AXQ Capital's ten largest holdings make up 7.4% of its $310M portfolio in Q2 2025.
  • AXQ Capital opened 340 new positions and closed 270 in Q2 2025.
  • AXQ Capital's portfolio value rose 24% quarter-over-quarter to $310M.

Based on AXQ Capital's 13F filing for Q2 2025, filed 12 Aug 2025.